-N T Zaveri Researcher Activity Profile

Research Author Detailed Information 

N T Zaveri Publication Rate By Year

N T Zaveri has published 1 paper(s) in 2006, 4 paper(s) in 2007, 2 paper(s) in 2008, for a total of 7 research publications in total.

N T Nt Zaveri Author Information

LAST NAME: zaveri

FIRST NAME: N T

INITIALS: nt

AFFILIATION:

Papers

N T Zaveri's Publication Record

1. Activities of mixed NOP and mu-opioid receptor ligands. Year Published: 2008
1Section of Pharmacology, Department of Experimental and Clinical Medicine, National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
2. Activities of mixed NOP and mu-opioid receptor ligands. Year Published: 2008
Section of Pharmacology, Department of Experimental and Clinical Medicine, National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
3. Regulation of the prepronociceptin gene and its effect on neuronal differentiation. Year Published: 2006
SRI International, Biosciences Division, 333 Ravenswood Ave, LA214A, Menlo Park, CA 94025, USA. naunihal.zaveri@sri.com
4. Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents. Year Published: 2007
SRI International, Center for Health Sciences, 333 Ravenswood Ave., Menlo Park, CA 94025, USA. Taline.Khroyan@sri.com
5. SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice. Year Published: 2007
Center for Health Sciences, SRI International, Menlo Park, CA 94025, USA. taline.khroyan@sri.com
6. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer. Year Published: 2007
Department of Tumor Endocrinology, Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, 2100, Copenhagen, Denmark, al@cancer.dk.
7. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer. Year Published: 2007
Department of Tumor Endocrinology, Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, 2100 Copenhagen, Denmark.